IP Verse

Amarin Pharmaceuticals Ireland patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of Amarin Pharmaceuticals Ireland opposed by its competitors

Explore Amarin Pharmaceuticals Ireland's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3815684
Sep 4, 2024Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy1
EP4056176
Apr 24, 2024Methods Of Reducing The Risk Of Cardiovascular Events In A Subject1
EP2800469
Aug 25, 2021Compositions And Methods For Lowering Levels Of High-Sensitivity (Hs-Crp) In A Subject2
EP3318255
Mar 10, 2021Compositions And Methods For Lowering Triglycerides Without Raising Ldl-C Levels In A Subject On Concomitant Statin Therapy3
EP3363433
Dec 9, 2020Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy3
EP3278665
Sep 9, 2020Stable Pharmaceutical Composition And Methods Of Using Same1
EP2596786
Nov 27, 2019Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia2
EP3037089
Nov 27, 2019Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia2

Top competitors of Amarin Pharmaceuticals Ireland

Top competitors of Amarin Pharmaceuticals Ireland based on patent oppositions.